China amended its law on the transformation of scientific and technological achievements in 2015, and the change redefined what universities may do with intellectual property generated from state-funded research. For R&D managers watching China's innovation pipeline, the revision is not a footnote to science policy. It is the legal mechanism that shifted control of publicly funded inventions from ministries to the institutions that produced them.

The amendment's core move concerns ownership and reward. Before 2015, results from state research programmes sat in a grey zone: universities held them, but disposing of them — licensing, selling, spinning out a company — required layers of approval and asset-valuation procedures modelled on the treatment of state-owned physical property. The 2015 revision cut that apparatus down.

What did the 2015 law actually change?

Three structural changes carry the weight.

• Decision rights moved inward. Universities, research institutes and their technology transfer offices gained authority to transfer or license results, without the prior approval and appraisal procedures previously applied to state assets.

• Reward floors rose sharply. The law set minimum shares of transfer income for the inventors themselves, where earlier rules prescribed smaller statutory percentages and capped practical payouts.

Leaders were brought into scope. The law created a safe pathway for the heads of institutions — the rectors and institute directors who sign the deals — rather than leaving them exposed to state-asset-loss liability whenever a licence priced below book value.

The mechanism matters more than the labels. Treat a patent as a piece of state property, and every transaction looks like a disposal of public wealth needing auditors. Treat it as a contract right the institution holds, and the transaction becomes a negotiation a technology transfer office can run in weeks. That is the switch the 2015 revision flipped.

Why should an R&D manager outside China care?

Because the ownership rule changed the behaviour attached to the patents. When inventors know they will keep a defined share of licensing income, filing and disclosure incentives strengthen; when institutions can transact without ministry sign-off, deal velocity rises. The law aligns the interests of three parties that previously pulled apart: the researcher who invents, the university that holds title, and the state that funded the work.

For anyone benchmarking against the US Bayh-Dole Act of 1980, the comparison is direct. Bayh-Dole gave American universities title to inventions from federal grants and let them license freely; the 2015 Chinese amendment pursued a similar end-state for a system built on stricter state-asset control, with heavier statutory reward minimums for individual inventors than Bayh-Dole contemplates.

What the law does not settle

A statutory change is not a measured result. Ownership reform addresses one bottleneck; it does not by itself build valuation expertise inside technology transfer offices, resolve disputes over the quality of university patents, or guarantee that licensing income reaches the researchers the reward provisions name. Any assessment of the 2015 law's effect on transfer volumes, spinout formation or patent quality rests on outcome data — patent counts, licence income figures, spinout registration rates — collected after the fact and interpreted with care about what else changed in the same period.

Nor does the law operate alone. It sits within a broader Chinese policy push of the mid-2010s to lift the commercialisation rate of research outputs, an effort documented by bodies such as CASRAI, which tracks research administration standards and analysed the ownership shift in its coverage of the legislation.

What comes next

The 2015 revision is now the settled baseline for how Chinese universities handle the intellectual property their laboratories produce, and institutions weighing partnership or licensing deals with Chinese counterparts should read that baseline as the point where institution-level decision-making, not ministry approval, became the operative rule.